title: Should we really worry about "launch delays" of new drugs in OECD countries?
authors.forename: Livio
authors.initials: L
authors.lastname: Garattini
authors.forename: Simone
authors.initials: S
authors.lastname: Ghislandi
mesh_terms: D015982:Bias; D003363:Cost Control; D019049:Developed Countries; D017277:Drug Approval / Q000191:economics / Q000458:organization & administration*; D005060:Europe; D006801:Humans